Trial

NIH: A Phase I Open-Label Trial To Investigate the Pharmacokinetic Interaction Between Rifabutin Or Rifampin And A Single Dose Of TMC207 In Healthy Subjects

Study Director
Start Date
0 / 0
Trial Phase
Trial Status
published
Current Enrollment
Target Enrollment
32
Overview
Compound Associations
Bedaquiline (TMC207) for DS-TB